CXCL10 production by CD103+ cDC1s was shown to be required for endogenous and adoptively transferred effector T cells migration into tumor sites, suggesting that the absence of intratumoral cDC1s may contribute to tumor immune escape mechanisms and limited responses to ICB [77]. Here, CXCL10 is linked to neoplasm.